Eventackle | Intelligence

Retail Show Saudi Announces Its Second Edition, Returning to Riyadh on 7–8 October 2026

Riyadh, 9 Feb 2026: Following an impressive first edition of Retail Show in October 2025, the Saudi Arabia’s National B2B retail innovation expo is set to return for its second edition on 7–8 October 2026 at the Marriott Hotel, Riyadh Airport, reaffirming Saudi Arabia’s role as a

Why 2026 Will Be a Defining Year for Global Biotech Collaboration

The biotechnology industry is entering 2026 at a critical inflection point. After years of accelerated innovation driven by global health challenges, supply chain disruptions, and rapid digital transformation, the focus is shifting. The question is no longer whether innovation is possible but how effectively it can be scaled, regulated, funded,

Novartis and Relation Therapeutics Enter Strategic Collaboration to Advance Atopic Disease Treatments

United Kingdom - 12 Dec 2025: UK-based biotech company Relation Therapeutics has announced a strategic, multi-program collaboration with Novartis aimed at accelerating the discovery and development of new therapies for atopic diseases, a group of immune-driven conditions affecting hundreds of millions of people globally. The partnership brings together Relation’s

Reprocessed Nuclear Material to Support Next-Generation Cancer Therapies in the UK

United Kingdom - 17 Dec, 2025: A pioneering collaboration between the UK’s life sciences and nuclear sectors is set to unlock a new pathway for advanced cancer treatment, with precision radiopharmaceuticals to be produced using reprocessed uranium from historic nuclear fuel. The initiative follows a long-term agreement between Bicycle

Collaboration Models That Work: How Academia, Big Pharma & Startups Are Co-Innovating

In today’s fast-moving biotechnology landscape, breakthrough innovation rarely comes from one organisation alone. The most transformative discoveries, whether in gene therapies, AI-driven drug discovery, cell and gene manufacturing, or precision diagnostics, are emerging from collaborative ecosystems that bridge the strengths of academia, big pharma, and early-stage startups. As the

Eventackle | Intelligence © 2026